Michael E. Hogan
40Patents
13h-index
47Co-inventors
81Inventor score
Filing activity: Dec 22, 1989 → Dec 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5176996A | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use | Emerging Cross-Sectional Technologies | 231 | Expired |
| US7195872B2 | High surface area substrates for microarrays and methods to make same | Performing Operations; Transporting | 117 | Expired |
| US6331441A | Multiplexed molecular analysis apparatus and method | Emerging Cross-Sectional Technologies | 105 | Expired |
| US5614503A | Amphipathic nucleic acid transporter | Human Necessities | 77 | Expired |
| US6312960A | Methods for fabricating an array for use in multiplexed biochemical analysis | Emerging Cross-Sectional Technologies | 62 | Expired |
| US7589184B2 | Stable protein storage and stable nucleic acid storage in recoverable form | Emerging Cross-Sectional Technologies | 59 | Active |
| US8431384B2 | Stable protein storage and stable nucleic acid storage in recoverable form | Emerging Cross-Sectional Technologies | 34 | Active |
| US6479301B1 | Methods for fabricating an array for use in multiplexed biochemical analysis | Emerging Cross-Sectional Technologies | 33 | Expired |
| US5905212A | Load and deflection measurement system for elastomeric bearings | Performing Operations; Transporting | 33 | Expired |
| US5650316A | Uses of triplex forming oligonucleotides for the treatment of human diseases | Emerging Cross-Sectional Technologies | 32 | Expired |
| US7341283B2 | High temperature flexible pipe joint | Mechanical Engineering; Lighting; Heating | 23 | Expired |
| US6288042A | Anti-viral guanosine-rich tetrad forming oligonucleotides | Chemistry; Metallurgy | 19 | Expired |
| US6184369A | Anti-viral guanosine-rich oligonucleotides | Chemistry; Metallurgy | 13 | Expired |
| US6323185A | Anti-viral guanosine-rich oligonucleotides and method of treating HIV | Electricity | 5 | Expired |
| US7964380B2 | Nanoparticles for manipulation of biopolymers and methods of thereof | Physics | 4 | Active |
| US5175266A | Nucleosides and oligonucleosides with a phosphate-free internucleoside backbone and process for preparing the same | Chemistry; Metallurgy | 4 | Expired |
| US6355785B1 | Guanosine-rich oligonucleotide integrase inhibitors | Electricity | 4 | Expired |
| US8910552B2 | Movable saw apparatus and method | Emerging Cross-Sectional Technologies | 3 | Active |
| US8288169B2 | Surface mediated self-assembly of nanoparticles | Emerging Cross-Sectional Technologies | 3 | Active |
| US11241490B2 | Nucleoside-modified RNA for inducing an immune response against zika virus | Emerging Cross-Sectional Technologies | 2 | Active |
| US10920274B2 | Nucleic acid coated submicron particles for authentication | Chemistry; Metallurgy | 2 | Active |
| US10308324B2 | Porch mounted variable reluctance measurement technology tendon tension monitoring system | Performing Operations; Transporting | 2 | Active |
| US6150339A | Anti-viral guanosine-rich oligonucleotides | Chemistry; Metallurgy | 1 | Expired |
| US6919180B2 | Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents | Chemistry; Metallurgy | 1 | Expired |
| US10556218B2 | Compositions and methods for entrapping protein on a surface | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.